Background:Rupture of the lateral ulnar collateral ligament (LUCL), particularly in cases of complex radial head fractures, can occur in up to 80% of cases. The outcomes of radial head replacement in such scenarios may not be optimal despite ligament augmentation. The objective was to compare the clinical outcomes of radial head replacement in elbows with an intact LUCL to those with a complete LUCL rupture managed with repair and augmentation. Methods:From January 2021 to June 2023, 27 patients underwent radial head replacement surgery using the Antea modular mobile radial head prosthesis (Adler Ortho). The patients were divided into 2 groups: 15 without rupture of the LUCL ligament (group A) and 12 with rupture (group B), in whom the ligament was repaired and augmented using non absorbable tape and anchors. Patients with other associated ligament injuries or fractures were excluded. Post-operative outcomes were assessed using the Mayo Elbow Performance Score (MEPS), the visual analog scale (VAS), and the range of motion (ROM) of the elbow. Follow-up assessments were conducted at 6, 12, 24, and 52 weeks postsurgery, and all patients completed the planned 52-week follow-up. Statistical analysis was performed using the Mann-Whitney U test. Results:At 12 weeks, the flexion-extension arc was significantly greater in group A compared with group B (median 122° vs. 113.5°, P = .02), corresponding clinically to median ROM of 10°-132° vs. 15°-126°. At 6, 24 and 52 weeks, there were no statistically significant differences in ROM between groups, although a mild residual extension deficit persisted in group B at 1 year (0°-137° vs. 7.5°-136°, P = .06). Final MEPS and VAS scores were comparable, with median MEPS of 100 and 95 (P = .18) and median VAS of 1.0 and 1.5 (P = .24) in groups A and B respectively. Conclusion:The results of radial head replacement, even in cases with LUCL tear and LUCL repair and augmentation are satisfactory, particularly from the third month onward. In cases of augmentation, a residual extension deficit of the elbow was observed; however, it did not cause functional impairment as measured by the MEPS.

Injury of the axillary artery after open reduction of a chronic shoulder dislocation is a rare and life-threatening condition. We present a case of an elderly woman suffering from a chronic shoulder dislocation which was addressed initially with close reduction and secondarily, after re-dislocation, with open reduction. Intraoperatively axillary artery rupture was established. By-pass restoration with a saphenous vein graft successfully managed the complication. The humeral head was immobilized in the glenoid with temporary K-wires. A CT-angiography was performed on the first and second days postoperatively.

Background: Celiac disease is a small intestine enteropathy. Gluten exposure in the diet of those who are vulnerable causes it. Susceptibility is determined by genetics. Despite advancements in technology, small intestinal biopsy remains the gold standard for diagnosing Celiac disease. Methods: Differentially expressed proteins related to celiac disease were collected from published research articles and considered for this study. Gene IDs of all proteins contained in the data set were identified using the NCBI Gene Database. The list of entrez gene IDs was then entered into the bio profiling software to look for protein-protein interactions between the gene IDs. Results: Using the Protein-Protein Interaction (PPI) spider model, numerous important signaling pathways implicated in the proteome of Celiac disease have been discovered. The p values of model D1 and D2 were <0.03 and <0.05, respectively. Model D1 depicts the pathway involved, which includes reverse cholesterol transport and model D2 depicts the pathway involved, which include anti-apoptosis, response to virus, and positive regulation of I-kappaB kinase/NF-kappaB cascade. Conclusions: The deregulation of several pathways and protein interaction networks is suggested by bioinformatic analysis of the differentially expressed proteins. Following validation, the unique biomarkers discovered can be utilized to better understand this illness and identify potential pharmaceutical therapies.

It is of greatest concern how COVID-19 is affecting pregnancy, mothers, and babies. Scientists are studying the impact of COVID-19 on pregnant women and babies and are understanding a little more every day. Reports show that there is an increased risk in pregnant women compared to nonpregnant women to get more serious illness due to COVID-19. Researchers are also investigating COVID-19 and its potential impact on a fetus. There are exceedingly rare cases of COVID-19 transmission to the fetus, and newborns can pick up COVID-19 when exposed. Vaccines are proved to be safe for pregnant women and help prevent both mother and the fetus from getting COVID-19 and are also highly effective to prevent COVID-19 infection, critical sickness, and fatalities in general. There are specific guidelines for labor and delivery during the COVID-19 pandemic which are to be imposed and followed to achieve safer and healthier childbirth. In this article, the overall influence of COVID-19 in pregnancy, its pathophysiology, effects on placenta and neonates, maternal and perinatal features and outcomes, the role of vaccination, available treatment options, and the guidelines to be followed during the pandemic are discussed based on the available scientific evidence.

Bilateral adrenal hemorrhage (BAH) is a rare and potentially fatal complication following total hip arthroplasty and low-molecule heparin use for DVT-prophylaxis. We present a case of a 64-year-old woman who sustained a femoral neck fracture, which was addressed with hip hemiarthroplasty. Twelve days postoperatively DVT was diagnosed and therapeutic doses of low-molecule-heparin were administered. The next day, CTPA was done searching for pulmonary embolism but BAH was shown and a short synacthen test confirmed the diagnosis of adrenal insufficiency. A therapeutic protocol with hydrocortisone was followed.

Since December 2020, the Pfizer-BioNTech BNT16B2b2 mRNA vaccine has been widely used to prevent COVID-19 infection. Vaccination is now widely regarded as the most effective way to reduce the pandemic's morbidity and death. Except for mild and infrequent adverse effects, almost all vaccinations are considered safe. One of the documented adverse effects of the COVID-19 immunizations is vaccine-induced immune thrombocytopenic purpura.